Taipei Fubon Commercial Bank (台北富邦銀行) has obtained regulatory approval to merge with Jih Sun International Bank (日盛銀行), after parent Fubon Financial Holding Co (富邦金控) completed its acquisition of Jih Sun Financial Holding Co (日盛金控) in November last year.
After the deal takes effect on April 1, Jih Sun International Bank would cease to exist and Fubon would become the nation’s third-largest bank in terms of assets, the Financial Supervisory Commission said on Tuesday.
Taipei Fubon Bank’s assets would expand to NT$4.27 trillion (US$140.77 billion) from NT$3.99 trillion, behind Bank of Taiwan’s (臺灣銀行) NT$5.95 trillion and CTBC Bank Co’s (中信銀行) NT$4.57 trillion, the commission said.
Photo: CNA
Taipei Fubon and Jih Sun Bank said the merger would provide wider business deployment and allow for better customer services.
They also expect it to help promote resource integration and increase market competitiveness.
Taipei Fubon Bank would retain all employees and 44 branches of Jih Sun Bank, raising its total number of branches to 179, the largest among private banks and the fifth-largest among all banks, Banking Bureau Chief Secretary Hou Li-yang (侯立洋) said.
It would also boost its market shares in the deposit and loan businesses in Taiwan, Hou said.
Taipei Fubon Bank posted a record net profit of NT$22.64 billion last year, up 21 percent year-on-year, thanks to higher fee incomes and investment gains.
However, Fubon Financial’s pre-tax profit of NT$60.6 billion last year fell short of market expectations, as its insurance arm was burdened by COVID-19-related claims, regulatory filings showed last week.
Fubon Financial last week announced that it would recruit 6,500 people to meet increasing demand for the company and its subsidiaries’ services.
The new openings range from overseas business development to information technology and security, data analytics, customer service and risk management, the company said.
The company would also recruit 50 to 60 management associates, it said.
The new hires are to start working in March, it added.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining
RSS